SCI Pharmtech, Inc. (4119.TW)
TWD 69.1
(1.32%)
TWD 69.1
(1.32%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.2 Billion | 899.73 Million | 864.21 Million | 2.68 Billion | 2.35 Billion | 1.93 Billion |
| Cost of Revenue | 853.83 Million | 608.55 Million | 656.12 Million | 1.41 Billion | 1.41 Billion | 1.19 Billion |
| Gross Profit | 350.32 Million | 291.17 Million | 208.08 Million | 1.27 Billion | 935.77 Million | 748.94 Million |
| Operating Expenses | 190.02 Million | 172.2 Million | 134.43 Million | 223.92 Million | 238.64 Million | 232.19 Million |
| Selling, General and Administrative Expenses | 140.92 Million | 132.56 Million | 104.08 Million | 180.56 Million | 199.73 Million | 195.34 Million |
| Research and Development Expenses | 49.09 Million | 39.64 Million | 30.34 Million | 43.36 Million | 38.91 Million | 36.85 Million |
| Other Expenses | - | 263.85 Million | 8.15 Million | -554.15 Million | 13.42 Million | 8.73 Million |
| Cost and Expenses | 1.04 Billion | 780.76 Million | 790.55 Million | 1.63 Billion | 1.65 Billion | 1.42 Billion |
| Operating Income | 160.3 Million | 404.29 Million | 63.3 Million | 469.71 Million | 705.2 Million | 516.74 Million |
| Interest Expense | 6.29 Million | 1.07 Million | 41 Thousand | 43 Thousand | 52 Thousand | 2000.00 |
| Income Tax Expense | 69.46 Million | 79.04 Million | 9.81 Million | 95.09 Million | 140.05 Million | 97.55 Million |
| Earnings before Tax | 364.19 Million | 387.82 Million | 65.5 Million | 455.21 Million | 711.16 Million | 544.78 Million |
| Net Income | 294.72 Million | 308.78 Million | 55.69 Million | 360.12 Million | 571.1 Million | 447.23 Million |
| Earnings Per Share Basic | 2.70 | 2.83 | 0.51 | 3.30 | 5.24 | 4.17 |
| Earnings Per Share Diluted | 2.69 | 2.82 | 0.51 | 3.28 | 5.19 | 4.17 |
| Weighted Average Shares Outstanding | 109.3 Million | 108.99 Million | 108.99 Million | 108.99 Million | 108.99 Million | 107.28 Million |
| Weighted Average Shares Outstanding (Diluted) | 109.6 Million | 109.32 Million | 109.2 Million | 109.89 Million | 110.02 Million | 107.28 Million |
| Gross Margin | 0.29 | 0.32 | 0.24 | 0.47 | 0.40 | 0.39 |
| EBIT Margin | 0.44 | 0.55 | 0.15 | 0.22 | 0.36 | 0.35 |
| Profit Margin | 0.24 | 0.34 | 0.06 | 0.13 | 0.24 | 0.23 |
| EBITDA | 529.61 Million | 492.06 Million | 142.8 Million | 603.01 Million | 847.94 Million | 647.96 Million |
| Earnings Before Tax Margin | 0.13 | 0.45 | 0.07 | 0.17 | 0.30 | 0.27 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 392.71 Million | 309.87 Million | 1.2 Billion | 291.41 Million | 257.84 Million | 313.11 Million |
| Cost of Revenue | 292.28 Million | 218 Million | 853.83 Million | 224.02 Million | 177.69 Million | 233.35 Million |
| Gross Profit | 100.42 Million | 91.87 Million | 350.32 Million | 67.39 Million | 80.15 Million | 79.76 Million |
| Operating Expenses | 45.35 Million | 46.84 Million | 190.02 Million | 58.48 Million | 43.89 Million | 43.41 Million |
| Selling, General and Administrative Expenses | 34.64 Million | 36.23 Million | - | 47.62 Million | 30.24 Million | 30.78 Million |
| Research and Development Expenses | 10.7 Million | 10.6 Million | - | 10.85 Million | 13.64 Million | 12.63 Million |
| Other Expenses | 1.35 Million | 2.68 Million | 217.93 Million | 2.12 Million | 1.19 Million | 212.89 Million |
| Cost and Expenses | 337.64 Million | 264.84 Million | 1.04 Billion | 282.5 Million | 221.58 Million | 276.76 Million |
| Operating Income | 55.07 Million | 58.17 Million | 372.93 Million | -6.97 Million | 44.14 Million | 257.63 Million |
| Interest Expense | 1.34 Million | 1.49 Million | 6.29 Million | 1.52 Million | 1.18 Million | 1.87 Million |
| Income Tax Expense | 228 Thousand | 11.33 Million | 69.46 Million | -6.68 Million | 9.04 Million | 51.81 Million |
| Earnings before Tax | 66.12 Million | 55.84 Million | 364.19 Million | -10.29 Million | 44.42 Million | 251.33 Million |
| Net Income | 62.19 Million | 44.5 Million | 294.72 Million | -3.61 Million | 35.37 Million | 199.51 Million |
| Earnings Per Share Basic | 0.52 | 0.37 | - | -0.03 | 0.32 | 1.63 |
| Earnings Per Share Diluted | 0.52 | 0.37 | - | -0.03 | 0.32 | 1.63 |
| Weighted Average Shares Outstanding | 119.5 Million | 120.29 Million | 109.3 Million | 119.5 Million | 109.2 Million | 122.62 Million |
| Weighted Average Shares Outstanding (Diluted) | 119.64 Million | 120.29 Million | 109.6 Million | 119.5 Million | 109.42 Million | 122.75 Million |
| Gross Margin | 0.26 | 0.30 | 0.29 | 0.23 | 0.31 | 0.25 |
| EBIT Margin | 0.29 | 0.35 | - | 0.13 | 0.31 | 0.93 |
| Profit Margin | 0.16 | 0.14 | 0.24 | -0.01 | 0.14 | 0.64 |
| EBITDA | 114.95 Million | 109.3 Million | - | 37.9 Million | 80.13 Million | 290.2 Million |
| Earnings Before Tax Margin | 0.14 | 0.19 | 0.31 | -0.02 | 0.17 | 0.82 |
095720
AOF
NYMT
SFPI
DIGAF
SANION